TEM

TEM

USD

Tempus AI Inc. Class A Common Stock

$84.490-0.565 (-0.664%)

Echtzeitkurs

Healthcare
Health Information Services
Vereinigte Staaten

Kursdiagramm

Loading Chart...

Schlüsselkennzahlen

Marktkennzahlen
Unternehmensfundamentaldaten
Handelsstatistiken

Marktkennzahlen

Eröffnung

$85.055

Hoch

$88.880

Tief

$83.940

Volumen

8.89M

Unternehmensfundamentaldaten

Marktkapitalisierung

14.7B

Branche

Health Information Services

Land

United States

Handelsstatistiken

Durchschnittliches Volumen

9.33M

Börse

NMS

Währung

USD

52-Wochen-Spanne

Tief $31.36Aktuell $84.490Hoch $104.32

Ähnliche Nachrichten

BusinessWire

Tempus to Participate in the Stifel 2025 Healthcare Conference

Tempus AI, Inc. (NASDAQ:TEM), a leader in artificial intelligence and precision medicine, today announced that it will participate in the Stifel 2025 Healthcare Conference on Thursday, November 13 in New York City. Jim

Mehr anzeigen
Tempus to Participate in the Stifel 2025 Healthcare Conference
Analyst Upgrades

Piper Sandler Maintains Neutral on Tempus AI, Raises Price Target to $105

Piper Sandler analyst David Westenberg maintains Tempus AI with a Neutral and raises the price target from $70 to $105.

Mehr anzeigen
Piper Sandler Maintains Neutral on Tempus AI, Raises Price Target to $105
Analyst Upgrades

BTIG Maintains Buy on Tempus AI, Raises Price Target to $96

BTIG analyst Mark Massaro maintains Tempus AI with a Buy and raises the price target from $85 to $96.

Mehr anzeigen
BTIG Maintains Buy on Tempus AI, Raises Price Target to $96
BusinessWire

Tempus to Report Third Quarter 2025 Financial Results on November 4

Tempus AI, Inc. (NASDAQ:TEM), a leader in artificial intelligence and precision medicine, today announced they will report financial results for the third quarter of 2025 on November 4, 2025. The company will hold the

Mehr anzeigen
Tempus to Report Third Quarter 2025 Financial Results on November 4
BusinessWire

Tempus Announces Six Abstracts Accepted for Presentation at the European Society for Medical Oncology Congress 2025

Tempus AI, Inc. (NASDAQ:TEM), a technology company leading the adoption of AI to advance precision medicine, today announced that six abstracts have been accepted for presentation at the European Society for Medical

Mehr anzeigen
Tempus Announces Six Abstracts Accepted for Presentation at the European Society for Medical Oncology Congress 2025
BusinessWire

Tempus Selected by ARPA-H to Provide CRO and Testing Services for the ADAPT Program, Advancing Precision Cancer Therapy

Tempus AI, Inc. (NASDAQ:TEM), a technology company leading the adoption of AI to advance precision medicine, today announced it has been selected by the Advanced Research Projects Agency for Health (ARPA-H), an agency